482 related articles for article (PubMed ID: 25559809)
61. Contribution of APC and MUTYH mutations to familial adenomatous polyposis susceptibility in Hungary.
Papp J; Kovacs ME; Matrai Z; Orosz E; Kásler M; Børresen-Dale AL; Olah E
Fam Cancer; 2016 Jan; 15(1):85-97. PubMed ID: 26446593
[TBL] [Abstract][Full Text] [Related]
62. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.
de Leon MP; Pedroni M; Benatti P; Percesepe A; Di Gregorio C; Foroni M; Rossi G; Genuardi M; Neri G; Leonardi F; Viel A; Capozzi E; Boiocchi M; Roncucci L
Gut; 1999 Jul; 45(1):32-8. PubMed ID: 10369701
[TBL] [Abstract][Full Text] [Related]
63. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
[TBL] [Abstract][Full Text] [Related]
64. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.
Esteban-Jurado C; Vila-Casadesús M; Garre P; Lozano JJ; Pristoupilova A; Beltran S; Muñoz J; Ocaña T; Balaguer F; López-Cerón M; Cuatrecasas M; Franch-Expósito S; Piqué JM; Castells A; Carracedo A; Ruiz-Ponte C; Abulí A; Bessa X; Andreu M; Bujanda L; Caldés T; Castellví-Bel S
Genet Med; 2015 Feb; 17(2):131-42. PubMed ID: 25058500
[TBL] [Abstract][Full Text] [Related]
65. Genetic testing and counseling for hereditary forms of colorectal cancer.
Petersen GM; Brensinger JD; Johnson KA; Giardiello FM
Cancer; 1999 Dec; 86(11 Suppl):2540-50. PubMed ID: 10630180
[TBL] [Abstract][Full Text] [Related]
66. First evidence for digenic inheritance in hereditary colorectal cancer by mutations in the base excision repair genes.
Morak M; Massdorf T; Sykora H; Kerscher M; Holinski-Feder E
Eur J Cancer; 2011 May; 47(7):1046-55. PubMed ID: 21195604
[TBL] [Abstract][Full Text] [Related]
67. Spectrum of mutations in genes associated with familial colorectal cancer syndrome (MLH1, MSH2, PMS2, MSH6, and APC): A not so common hereditary cancer syndrome in Indian population.
Bhai P; Kulshrestha S; Puri RD; Bijarnia Mahay S; Saxena R; Verma IC
Indian J Gastroenterol; 2020 Dec; 39(6):599-607. PubMed ID: 33191490
[TBL] [Abstract][Full Text] [Related]
68. DNA polymerase ε and δ exonuclease domain mutations in endometrial cancer.
Church DN; Briggs SE; Palles C; Domingo E; Kearsey SJ; Grimes JM; Gorman M; Martin L; Howarth KM; Hodgson SV; ; Kaur K; Taylor J; Tomlinson IP
Hum Mol Genet; 2013 Jul; 22(14):2820-8. PubMed ID: 23528559
[TBL] [Abstract][Full Text] [Related]
69. Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome.
Tresallet C; Brouquet A; Julié C; Beauchet A; Vallot C; Ménégaux F; Mitry E; Radvanyi F; Malafosse R; Rougier P; Nordlinger B; Laurent-Puig P; Boileau C; Emile JF; Muti C; Penna C; Hofmann-Radvanyi H
Int J Cancer; 2012 Mar; 130(6):1367-77. PubMed ID: 21520036
[TBL] [Abstract][Full Text] [Related]
70. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
[TBL] [Abstract][Full Text] [Related]
71. NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas.
Belhadj S; Quintana I; Mur P; Munoz-Torres PM; Alonso MH; Navarro M; Terradas M; Piñol V; Brunet J; Moreno V; Lázaro C; Capellá G; Valle L
Sci Rep; 2019 Jun; 9(1):9020. PubMed ID: 31227763
[TBL] [Abstract][Full Text] [Related]
72. Germline HNPCC gene variants have little influence on the risk for sporadic colorectal cancer.
Tomlinson IP; Beck NE; Homfray T; Harocopos CJ; Bodmer WF
J Med Genet; 1997 Jan; 34(1):39-42. PubMed ID: 9032648
[TBL] [Abstract][Full Text] [Related]
73. Characterization of a novel POLD1 missense founder mutation in a Spanish population.
Ferrer-Avargues R; Díez-Obrero V; Martín-Tomás E; Hernández-Illán E; Castillejo MI; Codoñer-Alejos A; Barberá VM; Sánchez-Heras AB; Segura Á; Juan MJ; Tena I; Castillejo A; Soto JL
J Gene Med; 2017 Apr; 19(4):. PubMed ID: 28306219
[TBL] [Abstract][Full Text] [Related]
74. Update on genetic predisposition to colorectal cancer and polyposis.
Valle L; de Voer RM; Goldberg Y; Sjursen W; Försti A; Ruiz-Ponte C; Caldés T; Garré P; Olsen MF; Nordling M; Castellvi-Bel S; Hemminki K
Mol Aspects Med; 2019 Oct; 69():10-26. PubMed ID: 30862463
[TBL] [Abstract][Full Text] [Related]
75. Suspected Hereditary Cancer Syndromes in Young Patients: Heterogeneous Clinical and Genetic Presentation of Colorectal Cancers.
Maletzki C; Hühns M; Bauer I; Prall F; Junghanss C; Henze L
Oncologist; 2019 Jul; 24(7):877-882. PubMed ID: 30683709
[TBL] [Abstract][Full Text] [Related]
76. Lynch syndrome in Tunisia: first description of clinical features and germline mutations.
Moussa SA; Moussa A; Kourda N; Mezlini A; Abdelli N; Zerimech F; Najjar T; Jilani SB; Porchet N; Ayed FB; Manai M; Buisine MP
Int J Colorectal Dis; 2011 Apr; 26(4):455-67. PubMed ID: 21311894
[TBL] [Abstract][Full Text] [Related]
77. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.
Guindalini RS; Win AK; Gulden C; Lindor NM; Newcomb PA; Haile RW; Raymond V; Stoffel E; Hall M; Llor X; Ukaegbu CI; Solomon I; Weitzel J; Kalady M; Blanco A; Terdiman J; Shuttlesworth GA; Lynch PM; Hampel H; Lynch HT; Jenkins MA; Olopade OI; Kupfer SS
Gastroenterology; 2015 Nov; 149(6):1446-53. PubMed ID: 26248088
[TBL] [Abstract][Full Text] [Related]
78. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
[TBL] [Abstract][Full Text] [Related]
79. Lynch-like syndrome: characterization and comparison with EPCAM deletion carriers.
Kang SY; Park CK; Chang DK; Kim JW; Son HJ; Cho YB; Yun SH; Kim HC; Kwon M; Kim KM
Int J Cancer; 2015 Apr; 136(7):1568-78. PubMed ID: 25110875
[TBL] [Abstract][Full Text] [Related]
80. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer.
Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC;
JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
